Lianhuan Pharmaceutical (600513) (600513，The closing price of the front list was 10.13 yuan)，The company intends to issue shares to the major shareholder Lianhuan Pharmaceutical Group to purchase 100%equity of Yangzhou Pharmaceuticals held by the latter，So as to completely solve the affiliated transaction between the company and the major shareholders。
 
According to the scheme，The evaluation value of all shareholders of Yangzhou Pharmaceuticals is 48.6831 million yuan，The transaction price is the same as the evaluation price，The issue price is set to 10.58 yuan/share，stake online sports bettingTherefore, stake betting appthis time it will issue 4.6014 million shares to Lianhuan Pharmaceutical Group。Yangzhou Pharmaceutical's sales revenue in 2011 was 218 million yuan，accounting for 67.28%of sales revenue of Lianhuan Pharmaceuticals in the same year，Therefore, this transaction constitutes a major asset reorganization。
 
"Daily Economic News" reporter noticed，Yangzhou Pharmaceutical's profitability is not prominent，Company 2010、2011、From January to July 2012, operating income was 179 million yuan, respectively、218 million yuan and 151 million yuan，But the net profit is only -64 million yuan、3.91 million yuan and 4.01 million yuan。For this，Lianhuan Pharmaceutical Group commitment，Yangzhou stake sports betting appstake betting appPharmaceutical 2012、The net profit in 2013 will not be less than 5.25 million yuan and 6.62 million yuan, respectively，If the above standards are not met，The difference will be supplemented from the listed company with cash with cash。